Correlation Between Akari Therapeutics and Soleno Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Soleno Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Soleno Therapeutics.
Diversification Opportunities for Akari Therapeutics and Soleno Therapeutics
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Soleno is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Soleno Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Soleno Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Soleno Therapeutics. In addition to that, Akari Therapeutics is 1.84 times more volatile than Soleno Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 4,025 in Soleno Therapeutics on August 25, 2024 and sell it today you would earn a total of 1,753 from holding Soleno Therapeutics or generate 43.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.56% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Soleno Therapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Soleno Therapeutics |
Akari Therapeutics and Soleno Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Soleno Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Soleno Therapeutics vs. Eliem Therapeutics | Soleno Therapeutics vs. HCW Biologics | Soleno Therapeutics vs. Scpharmaceuticals | Soleno Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |